OKYO Pharma (OKYO) Assets Average (2022 - 2025)

OKYO Pharma (OKYO) has reported Assets Average for 4 consecutive years, with $4.2 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Assets Average rose 90.41% year-over-year to $4.2 million in Q3 2025; TTM through Sep 2025 was $4.2 million, a 90.41% increase from a year earlier, with the FY2026 full-year figure at $12.3 million, changed N/A from the prior year.
• Assets Average was $4.2 million for Q3 2025 at OKYO Pharma, up from $2.2 million in the prior quarter.
• Over five years, Assets Average peaked at $5.7 million in Q1 2022 and troughed at $2.0 million in Q1 2024.
• A 4-year average of $3.8 million and a median of $4.0 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average plunged 58.77% in 2024 and surged 90.41% in 2025, its largest moves.
• Over 4 years, Assets Average stood at $5.7 million in 2022, then tumbled by 33.45% to $3.8 million in 2023, then sank by 42.36% to $2.2 million in 2024, then surged by 90.41% to $4.2 million in 2025.
• The last three Assets Average figures came in at $4.2 million (Q3 2025), $2.2 million (Q3 2024), and $2.0 million (Q1 2024), per Business Quant data.